Ionis Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
Great. Welcome, everyone. My name is Jess Fye. I'm a senior biotech analyst at JPMorgan, and we're continuing the 42nd Annual Healthcare Conference today with Ionis. I'm joined on stage by the company's CEO, Brett Monia. We're going to have a Q&A session after he gives a presentation on the business. (Operator Instructions) So with that, let me pass it over to Brett.
Thank you, Jess. Thank you, JPMorgan, for the opportunity to speak today on the great progress we're making at Ionis on behalf of the company. Ionis, today -- I'm very excited, very pleased to be presenting on the progress we're making at Ionis as this really great company enters into a new era, an era that's poised to transform human therapeutics to unlock better futures for patients and also to drive next-level value for all stakeholders. During my presentation, I will be making forward-looking statements.
So at Ionis, we have been and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |